(Q62113550)
Statements
Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD? (English)
Bipin N Savani
Madan Jagasia
Wichai Chinratanalab
Adetola Kassim
Brian Engelhardt
John Greer
Friedrich Schuening